Nicotinamide Riboside (NR)

nicotinamide riboside · NR · niagen

The other headline NAD⁺ precursor, marketed alongside NMN for cellular energy.

TypeSupplement / dietary

The grade answers: What does the human evidence support for: NAD⁺ precursor?

Grade

Moderate

The grade rates evidence quality — it is not advice to take or buy.

Class: Cellular metabolism
Primary use: NAD⁺ precursor
Evidence strength: medium
Last reviewed: 2026-07-01

EU authorised

Authorised as a novel food in the European Union. It can be lawfully sold as a supplement in Italy.

Source: Autorizzato UE come nicotinamide riboside cloruro (2017), Reg. (UE) 2015/2283

Bottom line

Like NMN, it reliably raises blood NAD⁺ in humans — and, like NMN, that hasn't yet translated into proven clinical benefit. Well tolerated, biologically real, clinically unproven.

What the evidence says

Nicotinamide riboside is NMN's close cousin, one step earlier in the NAD⁺ salvage pathway. Human trials consistently show it raises blood NAD⁺ and is safe over weeks to months — that part is solid. What's missing is the same thing missing for NMN: convincing effects on hard clinical endpoints (physical function, disease, longevity) rather than on the NAD⁺ number itself. Grade B mirrors NMN: a genuine biological effect without proof it changes how you age.

Key studies

[1]
Nicotinamide riboside raises NAD⁺ in humans (RCTs) · RCT
Reliable rise in blood NAD⁺; safe short-term.
Open on PubMed ↗
[2]
NR and clinical/functional outcomes · review
Surrogate markers move; hard endpoints not established.
Open on PubMed ↗
[3]
NAD⁺ precursors in aging (review) · review
Places NR and NMN in the same evidence bracket.
Open on PubMed ↗

See all studies on PubMed ↗

Scoped PubMed search, not a curated bibliography: the individual PMIDs for this entry have not yet been verified one by one. For that reason it is not used to support a high grade and is awaiting review.

Mechanism

Converted to NAD⁺ via the salvage pathway (NR → NMN → NAD⁺), supporting sirtuin and PARP activity involved in DNA repair and metabolic regulation.

Safety

Well tolerated in human trials with no serious adverse events at studied doses; long-term (multi-year) safety data are still limited.

Dosage context

Trials commonly use ~250–1000 mg/day. Head-to-head evidence that NR is meaningfully better or worse than NMN is lacking; the choice is often driven by price and marketing rather than data.

Examples of application

Taken as a daily morning capsule, much like NMN.
Often chosen over NMN on price, since the evidence is similar.
Sometimes paired with TMG on theory, though that pairing isn't proven.

From the field

NR and NMN are sold as rivals; in the evidence they're near-twins. We grade both B and make the same point: the NAD⁺ goes up, the proof that it makes you healthier isn't there yet.

Where to buy

Price and availability comparison across sellers operating in Italy. Prices are indicative — always verify on the seller's site.

Seller	Price	Shipping	Total	Unit price	Cost/studied dose	Updated
Amazon.it LongLife Nicotinamide Riboside Cloruro 300 mg Niagen + vitamina C - 30 capsule	€44.14	to verify	n/a	€1.47 /cap	—	2026-08-26	Go to store →
Amazon.it Tru Niagen NAD+ 300 mg - 90 capsule	€139.95	to verify	n/a	€1.55 /cap	—	2026-08-26	Go to store →

Cost per studied dose is computed only where the entry declares a cited dose and the label declares mg per serving. Where either is missing the column stays empty rather than estimating. Nucleo may earn a commission when you buy through some links. The commission does not raise your price and does not influence the ranking. The comparison is not exhaustive. How the comparison works.

Related molecules

NMNB

Follow this entry

We'll tell you if the grade for Nicotinamide Riboside (NR) changes.

One review a week: new evidence, grade changes and what was updated. No hype, no promotions disguised as news.

How we assign grades → Method